Computationally repurposing drugs for breast cancer subtypes using a network-based approach

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2105

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Computationally repurposing drugs for breast cancer subtypes using a network-based approach ; volume:23 ; number:1 ; day:20 ; month:4 ; year:2022 ; pages:1-36 ; date:12.2022
BMC bioinformatics ; 23, Heft 1 (20.4.2022), 1-36, 12.2022

Creator: Firoozbakht, Forough
Rezaeian, Iman
Rueda, Luis
Ngom, Alioune

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12859-022-04662-6

URN: urn:nbn:de:101:1-2022070308163683907915

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:22 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Firoozbakht, Forough
Rezaeian, Iman
Rueda, Luis
Ngom, Alioune
SpringerLink (Online service)

Other Objects (12)

Network-based drug repurposing for schizophrenia

Aufsatzsammlung

Drug repurposing

Network-based approach to prediction and population-based validation of in silico drug repurposing

Network-based approaches reveal potential therapeutic targets for host-directed antileishmanial therapy driving drug repurposing

Drug repurposing in cardiology

Drug Repurposing in Oncology

Drug repurposing with network reinforcement

Repurposing of approved cardiovascular drugs

Drug repurposing for cancer therapy

Genomic strategies for drug repurposing

Drug Repurposing through Network Medicine

Network-based drug sensitivity prediction

Network-based drug repurposing for schizophrenia

Aufsatzsammlung

Drug repurposing

Network-based approach to prediction and population-based validation of in silico drug repurposing

Network-based approaches reveal potential therapeutic targets for host-directed antileishmanial therapy driving drug repurposing

Drug repurposing in cardiology

Drug Repurposing in Oncology

Drug repurposing with network reinforcement

Repurposing of approved cardiovascular drugs

Drug repurposing for cancer therapy

Genomic strategies for drug repurposing

Drug Repurposing through Network Medicine

Network-based drug sensitivity prediction

Network-based drug repurposing for schizophrenia

Aufsatzsammlung

Drug repurposing

Network-based approach to prediction and population-based validation of in silico drug repurposing

Network-based approaches reveal potential therapeutic targets for host-directed antileishmanial therapy driving drug repurposing

Drug repurposing in cardiology

Drug Repurposing in Oncology

Drug repurposing with network reinforcement

Repurposing of approved cardiovascular drugs

Drug repurposing for cancer therapy

Genomic strategies for drug repurposing

Drug Repurposing through Network Medicine

Network-based drug sensitivity prediction

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Computationally repurposing drugs for breast cancer subtypes using a network-based approach

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Network-based drug repurposing for schizophrenia

Drug repurposing

Network-based approach to prediction and population-based validation of in silico drug repurposing

Network-based approaches reveal potential therapeutic targets for host-directed antileishmanial therapy driving drug repurposing

Drug repurposing in cardiology

Drug Repurposing in Oncology

Drug repurposing with network reinforcement

Repurposing of approved cardiovascular drugs

Drug repurposing for cancer therapy

Genomic strategies for drug repurposing

Drug Repurposing through Network Medicine

Network-based drug sensitivity prediction

Network-based drug repurposing for schizophrenia

Drug repurposing

Network-based approach to prediction and population-based validation of in silico drug repurposing

Network-based approaches reveal potential therapeutic targets for host-directed antileishmanial therapy driving drug repurposing

Drug repurposing in cardiology

Drug Repurposing in Oncology

Drug repurposing with network reinforcement

Repurposing of approved cardiovascular drugs

Drug repurposing for cancer therapy

Genomic strategies for drug repurposing

Drug Repurposing through Network Medicine

Network-based drug sensitivity prediction

Network-based drug repurposing for schizophrenia

Drug repurposing

Network-based approach to prediction and population-based validation of in silico drug repurposing

Network-based approaches reveal potential therapeutic targets for host-directed antileishmanial therapy driving drug repurposing

Drug repurposing in cardiology

Drug Repurposing in Oncology

Drug repurposing with network reinforcement

Repurposing of approved cardiovascular drugs

Drug repurposing for cancer therapy

Genomic strategies for drug repurposing

Drug Repurposing through Network Medicine

Network-based drug sensitivity prediction

Related objects

Reset password